FDA Adverse Event Malfunction Summary report: N

VITALITY

MDR report key: 1861041 · Received October 7, 2010

Report

Report Number
2124215-2010-15353
Event Type
Malfunction
Date Received
October 7, 2010
Date of Event
July 29, 2010
Report Date
October 19, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Removal / Correction Number
Z-1192-06 THRU Z-1194-06
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ME
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

UPON RETURN TO BOSTON SCIENTIFIC'S POST MARKET QUALITY ASSURANCE LABORATORY, A REVIEW OF DEVICE MEMORY REVEALED THE DEVICE DECLARED ITS END OF LIFE INDICATOR (EOL) AFTER EXPERIENCING A CHARGE TIME GREATER THAN THE EOL 30-SECOND CHARGE TIME LIMIT. ADDITIONAL LAB ANALYSIS AND TESTING SHOWED EOL WAS TRIGGERED EARLIER THAN EXPECTED DUE TO A HIGHER-THAN-TYPICAL BUILD-UP OF DEVICE INTERNAL BATTERY IMPEDANCE. ANALYSIS CONFIRMED THAT ALL THERAPIES WERE AVAILABLE.

Additional Manufacturer Narrative · 1

THE DEVICE SUBSEQUENTLY WAS EXPLANTED AND REPLACED WITH NO ADVERSE PATIENT EFFECTS. THE DEVICE'S REPORTING STATUS IS CHANGED TO SERIOUS INJURY FROM MALFUNCTION DUE TO EXPLANT WITH AN EARLY REPLACEMENT INDICATOR SUSPECTED.

Additional Manufacturer Narrative · 1

THIS REPORT WILL BE UPDATED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION FROM A BOSTON SCIENTIFIC FIELD REPRESENTATIVE THAT THIS DEVICE DISPLAYED AN END OF LIFE (EOL) BATTERY STATUS INDICATOR ASSOCIATED WITH A MIDDLE OF LIFE 2 BATTERY MEASUREMENT AND AN EXTENDED CHARGE TIME THAT EXCEEDED SPECIFICATIONS. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED, AND THE DEVICE REMAINS IMPLANTED AND IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITALITY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T180

Patients

Seq Age Sex Outcome Treatment
1 67 YR 1488TC| T180| 0148